Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.
Tanaka A, Shimabukuro M, Okada Y, Taguchi I, Yamaoka-Tojo M, Tomiyama H, Teragawa H, Sugiyama S, Yoshida H, Sato Y, Kawaguchi A, Ikehara Y, Machii N, Maruhashi T, Shima KR, Takamura T, Matsuzawa Y, Kimura K, Sakuma M, Oyama JI, Inoue T, Higashi Y, Ueda S, Node K; EMBLEM Trial Investigators. Tanaka A, et al. Among authors: ikehara y. Cardiovasc Diabetol. 2017 Apr 12;16(1):48. doi: 10.1186/s12933-017-0532-8. Cardiovasc Diabetol. 2017. PMID: 28403850 Free PMC article. Clinical Trial.
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial.
Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Yoshida H, Sato Y, Ikehara Y, Ueda S, Higashi Y, Node K; EMBLEM Investigators. Tanaka A, et al. Among authors: ikehara y. Diabetes Care. 2019 Oct;42(10):e159-e161. doi: 10.2337/dc19-1177. Epub 2019 Sep 18. Diabetes Care. 2019. PMID: 31533913 No abstract available.
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial.
Tanaka A, Sata M, Okada Y, Teragawa H, Eguchi K, Shimabukuro M, Taguchi I, Matsunaga K, Kanzaki Y, Yoshida H, Ishizu T, Ueda S, Kitakaze M, Murohara T, Node K; PROTECT study investigators. Tanaka A, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):165-172. doi: 10.1093/ehjcvp/pvac059. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36308299 Free PMC article. Clinical Trial.
Effects of Low-Dose Colchicine on Serum High-Sensitivity C-Reactive Protein Level in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose-Finding Study.
Miwa Y, Mutoh A, Morimoto T, Ikehara Y, Yasu T, Koba S, Ako J, Higashi Y, Kajikawa M, Uehara H, Ishikawa K, Sakuma I, Tomiyama H, Node K, Kumagai Y, Ueda S. Miwa Y, et al. Among authors: ikehara y. Biomed Hub. 2022 Dec 5;7(3):156-164. doi: 10.1159/000527411. eCollection 2022 Sep-Dec. Biomed Hub. 2022. PMID: 36643381 Free PMC article.
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial.
Tanaka A, Shimabukuro M, Teragawa H, Yoshida H, Okada Y, Takamura T, Taguchi I, Toyoda S, Tomiyama H, Ueda S, Higashi Y, Node K; EMBLEM Investigators. Tanaka A, et al. Hypertens Res. 2024 Sep;47(9):2295-2302. doi: 10.1038/s41440-024-01725-4. Epub 2024 May 24. Hypertens Res. 2024. PMID: 38789538 Clinical Trial.
Comparison of blood pressure values-self-measured at home, measured at an unattended office, and measured at a conventional attended office.
Asayama K, Ohkubo T, Rakugi H, Miyakawa M, Mori H, Katsuya T, Ikehara Y, Ueda S, Ohya Y, Tsuchihashi T, Kario K, Miura K, Hasebe N, Ito S, Umemura S; Japanese Society of Hypertension Working Group on the COmparison of Self-measured home, Automated unattended office and Conventional attended office blood pressure (COSAC) study. Asayama K, et al. Among authors: ikehara y. Hypertens Res. 2019 Nov;42(11):1726-1737. doi: 10.1038/s41440-019-0287-6. Epub 2019 Jun 21. Hypertens Res. 2019. PMID: 31222188
Direct comparison of the reproducibility of in-office and self-measured home blood pressures.
Asayama K, Ohkubo T, Rakugi H, Miyakawa M, Mori H, Katsuya T, Ikehara Y, Ueda S, Ohya Y, Tsuchihashi T, Kario K, Miura K, Ito S, Umemura S; Japanese Society of Hypertension Working Group on the COmparison of Self-measured home, Automated unattended office, Conventional attended office blood pressure (COSAC) study. Asayama K, et al. Among authors: ikehara y. J Hypertens. 2022 Feb 1;40(2):398-407. doi: 10.1097/HJH.0000000000003026. J Hypertens. 2022. PMID: 34620775 Free PMC article.
345 results